What This Bill Does · Plain English
GovGreed Synthesis · AI extraction
This bill directs the Government Accountability Office (GAO) to conduct a study on the use of remote monitoring for individuals prescribed opioids. The study will assess the evidence on efficacy, outcomes, and potential cost savings; evaluate current usage; and make recommendations to improve availability and coverage through federal programs.
Action Timeline
2025-03-27
Referred to the House Committee on Energy and Commerce.
2025-03-27
Introduced in House
2025-03-27
Introduced in House
Frequently Asked Questions
Did HR.2404 pass?
HR.2404 is still alive. Current stage: COMMITTEE. Pass likelihood: 40%.
What does HR.2404 do?
This bill directs the Government Accountability Office (GAO) to conduct a study on the use of remote monitoring for individuals prescribed opioids. The study will assess the evidence on efficacy, outcomes, and potential cost savings; evaluate current usage; and make recommendations to improve availability and coverage through federal programs.
Who sponsored HR.2404?
HR.2404 was sponsored by Troy Balderson (R-Ohio).
Full Bill Text
119 HR 2404 IH: Remote Opioid Monitoring Act of 2025 U.S. House of Representatives 2025-03-27 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 2404 IN THE HOUSE OF REPRESENTATIVES March 27, 2025 Mr. Balderson (for himself and Ms. Kelly of Illinois ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To provide for a study on the effects of remote monitoring on individuals who are prescribed opioids. 1. Short title This Act may be cited as the Remote Opioid Monitoring Act of 2025 . 2. Providing for a study on the effects of remote monitoring on individuals who are prescribed opioids (a) In general Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall conduct a study and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions and the Committee on Finance of the Senate a report on the use of remote monitoring with respect to individuals who are prescribed opioids. (b) Report The report described in subsection (a) shall include— (1) an assessment of scientific evidence related to the efficacy, individual outcomes, and potential cost savings associated with remote monitoring for individuals who are prescribed opioids compared to such individuals who are not so monitored; (2) an assessment of the current prevalence of remote monitoring for individuals who are prescribed opioids, including the use of such monitoring for such individuals in other countries; and (3) recommendations to improve availability, access, and coverage for remote monitoring for individuals who are prescribed opioids, including through changes to Federal health care programs (as defined in section 1128B of the Social Security Act ( 42 U.S.C. 1320a–7b )) and, if determined appropriate by the Comptroller General, an identification of cohorts of individuals who stand to benefit the most from remote monitoring when prescribed opioids.
Loading intelligence layer…